SMN1 and proximal spinal muscular atrophy: Despite major therapeutic advancements focusing on restoring SMN levels, which have notably enhanced both lifespan and quality of life in SMA patients, complete phenotypic rescue remains elusive (Finkel et al., 2016; Chiriboga, 2017; McMillan et al., 2022).